These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 7939745)

  • 1. Molecular biology of prostate cancer.
    Isaacs WB; Bova GS; Morton RA; Bussemakers MJ; Brooks JD; Ewing CM
    Semin Oncol; 1994 Oct; 21(5):514-21. PubMed ID: 7939745
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular biology of prostate cancer progression.
    Isaacs WB; Bova GS; Morton RA; Bussemakers MJ; Brooks JD; Ewing CM
    Cancer Surv; 1995; 23():19-32. PubMed ID: 7621457
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular genetics of prostate cancer.
    Isaacs WB
    Cancer Surv; 1995; 25():357-79. PubMed ID: 8718527
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic alterations in prostate cancer.
    Isaacs WB; Bova GS; Morton RA; Bussemakers MJ; Brooks JD; Ewing CM
    Cold Spring Harb Symp Quant Biol; 1994; 59():653-9. PubMed ID: 7587126
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chromosome 5 suppresses tumorigenicity of PC3 prostate cancer cells: correlation with re-expression of alpha-catenin and restoration of E-cadherin function.
    Ewing CM; Ru N; Morton RA; Robinson JC; Wheelock MJ; Johnson KR; Barrett JC; Isaacs WB
    Cancer Res; 1995 Nov; 55(21):4813-7. PubMed ID: 7585512
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reduction of E-cadherin levels and deletion of the alpha-catenin gene in human prostate cancer cells.
    Morton RA; Ewing CM; Nagafuchi A; Tsukita S; Isaacs WB
    Cancer Res; 1993 Aug; 53(15):3585-90. PubMed ID: 8339265
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Functional Loss of the gamma-catenin gene through epigenetic and genetic pathways in human prostate cancer.
    Shiina H; Breault JE; Basset WW; Enokida H; Urakami S; Li LC; Okino ST; Deguchi M; Kaneuchi M; Terashima M; Yoneda T; Shigeno K; Carroll PR; Igawa M; Dahiya R
    Cancer Res; 2005 Mar; 65(6):2130-8. PubMed ID: 15781623
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Loss of heterozygosity at chromosome 16q in prostate adenocarcinoma: identification of three independent regions.
    Latil A; Cussenot O; Fournier G; Driouch K; Lidereau R
    Cancer Res; 1997 Mar; 57(6):1058-62. PubMed ID: 9067271
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synergy of p53 and Rb deficiency in a conditional mouse model for metastatic prostate cancer.
    Zhou Z; Flesken-Nikitin A; Corney DC; Wang W; Goodrich DW; Roy-Burman P; Nikitin AY
    Cancer Res; 2006 Aug; 66(16):7889-98. PubMed ID: 16912162
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alterations of the cadherin-catenin cell adhesion system in cancers.
    Kanai Y; Oda T; Shimoyama Y; Ochiai A; Oyama T; Yoshiura K; Akimoto S; Yamada T; Hirohashi S
    Princess Takamatsu Symp; 1994; 24():51-62. PubMed ID: 8983063
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor suppressor genes in prostatic oncogenesis.
    Bookstein R
    J Cell Biochem Suppl; 1994; 19():217-23. PubMed ID: 7823594
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic pathways of two types of gastric cancer.
    Tahara E
    IARC Sci Publ; 2004; (157):327-49. PubMed ID: 15055305
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular aspects of adhesion-epigenetic mechanisms for inactivation of the E-Cadherin-mediated cell adhesion system in cancers.
    Hirohashi S
    Verh Dtsch Ges Pathol; 2000; 84():28-32. PubMed ID: 11217445
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel colon cancer cell lines leading to better understanding of the diversity of respective primary cancers.
    Vécsey-Semjén B; Becker KF; Sinski A; Blennow E; Vietor I; Zatloukal K; Beug H; Wagner E; Huber LA
    Oncogene; 2002 Jul; 21(30):4646-62. PubMed ID: 12096341
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic alterations in incidentally diagnosed, transitional zone prostate cancer: a seven year follow-up.
    Crundwell MC; Arkell DG; Gearty J; Phillips SM
    J Urol; 1997 Oct; 158(4):1568-75. PubMed ID: 9302175
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Three distinct commonly deleted regions of chromosome arm 16q in human primary and metastatic prostate cancers.
    Suzuki H; Komiya A; Emi M; Kuramochi H; Shiraishi T; Yatani R; Shimazaki J
    Genes Chromosomes Cancer; 1996 Dec; 17(4):225-33. PubMed ID: 8946204
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Deletion, methylation, and expression of the NKX3.1 suppressor gene in primary human prostate cancer.
    Asatiani E; Huang WX; Wang A; Rodriguez Ortner E; Cavalli LR; Haddad BR; Gelmann EP
    Cancer Res; 2005 Feb; 65(4):1164-73. PubMed ID: 15734999
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Altered expression of E-cadherin in hepatocellular carcinoma: correlations with genetic alterations, beta-catenin expression, and clinical features.
    Wei Y; Van Nhieu JT; Prigent S; Srivatanakul P; Tiollais P; Buendia MA
    Hepatology; 2002 Sep; 36(3):692-701. PubMed ID: 12198663
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aberrant CpG island hypermethylation of multiple genes in prostate cancer and prostatic intraepithelial neoplasia.
    Kang GH; Lee S; Lee HJ; Hwang KS
    J Pathol; 2004 Feb; 202(2):233-40. PubMed ID: 14743506
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic alterations in untreated metastases and androgen-independent prostate cancer detected by comparative genomic hybridization and allelotyping.
    Cher ML; Bova GS; Moore DH; Small EJ; Carroll PR; Pin SS; Epstein JI; Isaacs WB; Jensen RH
    Cancer Res; 1996 Jul; 56(13):3091-102. PubMed ID: 8674067
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.